MX2018000528A - Dispositivo para la deteccion de proteinas mal plegadas y metodos de uso del mismo. - Google Patents

Dispositivo para la deteccion de proteinas mal plegadas y metodos de uso del mismo.

Info

Publication number
MX2018000528A
MX2018000528A MX2018000528A MX2018000528A MX2018000528A MX 2018000528 A MX2018000528 A MX 2018000528A MX 2018000528 A MX2018000528 A MX 2018000528A MX 2018000528 A MX2018000528 A MX 2018000528A MX 2018000528 A MX2018000528 A MX 2018000528A
Authority
MX
Mexico
Prior art keywords
methods
misfolded proteins
proteins
disorders
use therof
Prior art date
Application number
MX2018000528A
Other languages
English (en)
Inventor
l davis Wendy
Levenson Daniel
Original Assignee
Gestvision Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gestvision Inc filed Critical Gestvision Inc
Publication of MX2018000528A publication Critical patent/MX2018000528A/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2828—Prion diseases
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2835—Movement disorders, e.g. Parkinson, Huntington, Tourette

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La presente invención se refiere a dispositivos de diagnóstico así como a métodos de uso de estos dispositivos para detectar las proteínas de interés asociadas con enfermedades o trastornos en mamíferos; en particular, las proteínas de interés pueden ser proteínas mal plegadas asociadas con ciertos trastornos de proteínas mal plegadas en mamíferos que incluyen esos mamíferos que se sospecha que tienen o que están en riesgo de tener esos trastornos.
MX2018000528A 2015-07-15 2016-07-15 Dispositivo para la deteccion de proteinas mal plegadas y metodos de uso del mismo. MX2018000528A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562192962P 2015-07-15 2015-07-15
PCT/US2016/042426 WO2017011727A1 (en) 2015-07-15 2016-07-15 Device for detecting misfolded proteins and methods of use therof

Publications (1)

Publication Number Publication Date
MX2018000528A true MX2018000528A (es) 2018-08-21

Family

ID=57758210

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2018000528A MX2018000528A (es) 2015-07-15 2016-07-15 Dispositivo para la deteccion de proteinas mal plegadas y metodos de uso del mismo.
MX2022010954A MX2022010954A (es) 2015-07-15 2018-01-12 Dispositivo para la deteccion de proteinas mal plegadas y metodos de uso del mismo.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2022010954A MX2022010954A (es) 2015-07-15 2018-01-12 Dispositivo para la deteccion de proteinas mal plegadas y metodos de uso del mismo.

Country Status (16)

Country Link
US (4) US10564153B2 (es)
EP (2) EP4036574A1 (es)
JP (3) JP6885608B2 (es)
CN (2) CN108291905B (es)
AR (1) AR105379A1 (es)
AU (2) AU2016293547C1 (es)
BR (1) BR112017028627A2 (es)
CA (1) CA2989444A1 (es)
DK (1) DK3322985T3 (es)
ES (1) ES2903034T3 (es)
HK (1) HK1247282A1 (es)
MX (2) MX2018000528A (es)
PL (1) PL3322985T3 (es)
PT (1) PT3322985T (es)
TW (3) TWI800009B (es)
WO (1) WO2017011727A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11186557B2 (en) * 2015-09-29 2021-11-30 Hamamatsu Photonics K.K. Method for purifying pure thioflavin T, method for producing pure thioflavin T, composition including thioflavin T, and amyloid detection method
TWI698641B (zh) * 2017-12-28 2020-07-11 大陸商浙江數問生物技術有限公司 一種檢測錯誤折疊蛋白質的裝置、試劑盒和方法
WO2019128506A1 (zh) * 2017-12-28 2019-07-04 浙江数问生物技术有限公司 一种检测错误折叠蛋白质的装置、试剂盒和方法
AU2021384645A1 (en) 2020-11-21 2023-07-06 Shuwen Biotech Co., Ltd. Apparatus and method for detecting misfolded protein in biological sample
WO2022193028A1 (en) * 2021-03-19 2022-09-22 Kenota Inc. Assay membrane test region localization

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2684488A (en) * 1988-06-27 1990-01-04 Carter-Wallace, Inc. Test device and method for colored particle immunoassay
US5252496A (en) * 1989-12-18 1993-10-12 Princeton Biomeditech Corporation Carbon black immunochemical label
US5451504A (en) * 1991-07-29 1995-09-19 Serex, Inc. Method and device for detecting the presence of analyte in a sample
US5804452A (en) * 1995-04-27 1998-09-08 Quidel Corporation One step urine creatinine assays
GB2391068A (en) 2002-07-18 2004-01-28 Sensor Tech Ltd A lateral flow through device comprising an electrochemical sesor
ATE392618T1 (de) * 2003-06-03 2008-05-15 Bayer Healthcare Llc Nativer analyt als referenz in lateralfluss- assays
WO2005010533A2 (en) * 2003-07-31 2005-02-03 Hadasit Medical Research Services & Development Ltd. Methods and kits for the detection of prion diseases
US7763454B2 (en) 2004-07-09 2010-07-27 Church & Dwight Co., Inc. Electronic analyte assaying device
EP1946121A2 (en) 2005-10-27 2008-07-23 Yale University, Inc. Urinary proteomic biomarker patterns in preeclampsia
TW200801190A (en) * 2005-11-21 2008-01-01 Trustees Of The University Of Alabama For And On Behalf Of The University Of Board Of Regulators of protein misfolding and aggregation and methods of using the same
WO2009003177A1 (en) * 2007-06-27 2008-12-31 Inbios International, Inc. Lateral flow assay system and methods for its use
CN110187119B (zh) * 2008-10-31 2022-07-29 耶鲁大学 子痫前期检测和治疗的方法和组合物
CN105713968A (zh) * 2009-03-19 2016-06-29 株式会社钟化 核酸的检测方法以及试剂盒、装置
TWM384314U (en) * 2010-01-29 2010-07-11 Nat Univ Chin Yi Technology Protein folding calculation device
JP2012068064A (ja) * 2010-09-22 2012-04-05 Pilot Ink Co Ltd 液体試料検査具及び液体検査具の採液部構造
DE102011003944A1 (de) * 2011-02-10 2012-08-16 Oxprotect Gmbh Detektion und Entfernung von missgefalteten Proteinen/Peptiden
EP2602620A1 (en) 2011-12-07 2013-06-12 Nxp B.V. An electronic lateral flow test arrangement and method
EP2928494A4 (en) * 2012-12-07 2016-11-02 Biogen Internat Neuroscience Gmbh METHOD FOR REDUCING AMYLOIDER PLAQUE OF BRAIN WITH ANTI-ASS ANTIBODIES
MX2015010174A (es) * 2013-02-08 2016-03-31 Univ Iowa Res Found Herramientas de diagnostico para predecir la presentacion de preeclampsia.
JP6182027B2 (ja) * 2013-09-10 2017-08-16 デンカ生研株式会社 Ｂ型インフルエンザウイルスの測定方法
JP6697394B2 (ja) 2014-04-10 2020-05-20 イェール ユニバーシティーＹａｌｅ Ｕｎｉｖｅｒｓｉｔｙ 異常折り畳みタンパク質を検出するための方法および組成物
TWM494304U (zh) * 2014-10-31 2015-01-21 Anatech Co Ltd 非酵素型糖化血色素檢測裝置

Also Published As

Publication number Publication date
US20210318299A1 (en) 2021-10-14
TW201716778A (zh) 2017-05-16
US11073516B2 (en) 2021-07-27
MX2022010954A (es) 2022-10-07
BR112017028627A2 (pt) 2018-09-04
JP2018527587A (ja) 2018-09-20
DK3322985T3 (da) 2022-01-17
CN111965343B (zh) 2023-05-09
CN111965343A (zh) 2020-11-20
WO2017011727A1 (en) 2017-01-19
US10564153B2 (en) 2020-02-18
ES2903034T3 (es) 2022-03-30
JP6885608B2 (ja) 2021-06-16
AU2016293547B2 (en) 2023-03-09
PT3322985T (pt) 2022-01-13
US20230251251A1 (en) 2023-08-10
AU2023201820A1 (en) 2023-04-27
AR105379A1 (es) 2017-09-27
AU2016293547A1 (en) 2018-01-18
TW202208853A (zh) 2022-03-01
CN108291905B (zh) 2020-09-11
CA2989444A1 (en) 2017-01-19
CN108291905A (zh) 2018-07-17
JP2021073434A (ja) 2021-05-13
AU2016293547C1 (en) 2023-06-29
US20170016891A1 (en) 2017-01-19
EP3322985A4 (en) 2019-01-09
TW202331255A (zh) 2023-08-01
JP2023027284A (ja) 2023-03-01
EP4036574A1 (en) 2022-08-03
HK1247282A1 (zh) 2018-09-21
PL3322985T3 (pl) 2022-02-21
US20200141932A1 (en) 2020-05-07
TWI744239B (zh) 2021-11-01
TWI800009B (zh) 2023-04-21
EP3322985B1 (en) 2021-10-13
EP3322985A1 (en) 2018-05-23

Similar Documents

Publication Publication Date Title
MX2022010954A (es) Dispositivo para la deteccion de proteinas mal plegadas y metodos de uso del mismo.
BR112017006664A2 (pt) terapias de combinação
EA201791029A1 (ru) Антитела против интерлейкина-33 и их применение
EA201692477A1 (ru) Композиции и способы применения для лечения метаболических расстройств
EA201692529A1 (ru) Способы и композиции для лечения расстройств с использованием фоллистатиновых полипептидов
EA201690969A1 (ru) Способы и композиции для лечения связанных со старением состояний
BR112016018408A2 (pt) moléculas de anticorpo à lag-3 e usos das mesmas
MX2021001659A (es) Esteroides neuroactivos, composiciones, y usos de los mismos.
MX2015017331A (es) Anticuerpos anti fc similar a receptor 5 (fcrh5).
EA201591740A1 (ru) Вирусы болезни ньюкасла и их применение
EA201691607A1 (ru) Микроорганоиды и способы их получения и применения
WO2015031808A3 (en) Diagnostic methods and compositions for treatment of glioblastoma
NZ720769A (en) Anti-siglec-8 antibodies and methods of use thereof
EA201890747A1 (ru) Способы лечения воспалительных заболеваний
MX2017006242A (es) Determinacion de niveles de glicosaminoglicanos mediante espectrometria de masas.
MX2016003002A (es) Metodos para determinar la respuesta a la terapia.
MX2018010536A (es) Metodos y composiciones para deteccion y diagnostico de enfermedades renales y enfermedades periodontales.
EP3134733A4 (en) Compositions and methods for treating subjects with immune-mediated diseases
CL2016000939A1 (es) Compuestos derivados de pirimidina con actividad inhibidora de syk uso en el tratamiento de una condición inmune, enfermedades inflamatorias, trastornos alérgicos, lupus eritomatosos, epoc, bronquitis, rinitis alérgica, asma, entre otras composición farmacéutica que los comprende.
MX2017013729A (es) Deteccion especifica de isoformas de clusterina.
IL255612A (en) Methods for diagnosing and determining treatment for Cushing's syndrome
PH12016501434A1 (en) Compositions for use in the treatment of allergic conditions
WO2015022077A8 (en) Novel anti-fc-gamma receptor iib antibodies and uses thereof
MX2015009153A (es) Uso de agonistas del receptor nicotinico de acetilcolina alfa 7.
WO2014169011A3 (en) Methods for treating immune diseases